Division of General Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Department of Medicine, Harvard Medical School, Boston, Massachusetts.
JAMA Netw Open. 2021 May 3;4(5):e2110079. doi: 10.1001/jamanetworkopen.2021.10079.
This cross-sectional study assesses the availability of the direct oral anticoagulant reversal agents idarucizumab and andexanet alfa in US hospitals.
本横断面研究评估了直接口服抗凝剂逆转剂依达鲁单抗和andexanet alfa 在美国医院中的可及性。